|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Entrada Therapeutics, Inc. (TRDA) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
16 |
|
|
|
Total
Direct Shares :
|
1,074,888 |
|
|
Total
Indirect Shares :
|
29,459,508 |
| |
%
Held by Insiders:
|
3.44% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Wentworth Kory James |
Chief Financial Officer |
2025-04-03 |
120,670 |
|
0 |
| Doshi Dipal |
CEO, Director |
2025-03-03 |
424,387 |
|
0 |
| Dowden Nathan J |
President & COO |
2025-03-03 |
180,805 |
|
0 |
| Sethuraman Natarajan |
President, Research & Develop. |
2025-03-03 |
199,659 |
|
0 |
| Kim Peter S |
Director |
2024-06-03 |
104,330 |
|
0 |
| Kreher Nerissa |
Chief Medical Officer |
2023-09-06 |
40,037 |
2021-12-29 |
0 |
| Baker Bros. Advisors (gp) Llc |
10% Owner |
2022-05-16 |
0 |
2022-06-06 |
4,501,658 |
| Crowley John F |
Director |
2022-01-12 |
5,000 |
2022-01-12 |
32,864 |
| Foley Todd |
Director, 10% Owner |
2021-11-02 |
0 |
2021-11-02 |
4,425,784 |
| Mpm Bioventures 2018 Gp Llc |
10% Owner |
2021-11-02 |
0 |
2024-12-11 |
4,381,062 |
| Roche Finance Ltd |
10% Owner |
2021-11-02 |
0 |
2021-11-02 |
2,813,525 |
| Redmile Biopharma Investments Iii, L.p. |
10% Owner |
2021-11-02 |
0 |
2021-11-02 |
1,954,420 |
| Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
2021-11-02 |
0 |
2024-12-11 |
4,381,062 |
| Schwab Andrew J. |
10% Owner |
|
0 |
2021-11-02 |
1,132,357 |
| Parmar Kush |
Director, 10% Owner |
|
0 |
2021-11-02 |
1,132,357 |
| Baker Julian |
10% Owner |
|
0 |
2021-12-14 |
4,704,419 |
|
|
